David M. Mott

Insider Reports History

Location
1119 St. Paul Street, Baltimore, MD
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David M. Mott:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Director Common Stock 2.97M $10.7M $3.62 Jun 18, 2025 Direct
IMARA Inc. Director Common Stock 229K $3.47M $15.14 Jun 2, 2022 Direct
NOVAVAX INC Director Common Stock 60.9K $377K $6.19 Jun 12, 2025 Direct
NOVAVAX INC Director Stock Option (Right to Buy) 28.3K $182K $6.42 Jun 20, 2025 Direct
NOVAVAX INC Director Restricted Stock Units 18.9K $145K $13.90 Jun 20, 2025 Direct
Epizyme, Inc. Director Stock Option (Right to Buy) 41K $23K $0.56 May 17, 2022 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54.1K $0 $2.32 Jun 18, 2025 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 1.58M Jul 1, 2024 Direct
Mersana Therapeutics, Inc. Director Stock Option (right to buy) 61.5K Jun 12, 2025 Direct
IMARA Inc. Director Stock Options (Right to Buy) 8.5K Jun 2, 2022 Direct
Epizyme, Inc. Director Common Stock, par value $0.0001 0 $1.41 Aug 12, 2022 Direct
Epizyme, Inc. Director Common Stock, par value $0.0001 0 $1.41 Aug 12, 2022 Indirect

Insider Reports Filed by David M. Mott

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Jun 20, 2025 2 $182K 4 Jun 24, 2025 Director
ARDX ARDELYX, INC. Jun 18, 2025 3 $0 4 Jun 23, 2025 Director
ARDX ARDELYX, INC. Jun 16, 2025 1 $726K 4 Jun 18, 2025 Director
NVAX NOVAVAX INC Jun 12, 2025 2 $0 4 Jun 13, 2025 Director
MRSN Mersana Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 13, 2025 Director
ARDX ARDELYX, INC. Jun 9, 2025 1 $737K 4 Jun 11, 2025 Director
ARDX ARDELYX, INC. May 15, 2025 1 $329K 4 May 19, 2025 Director
ARDX ARDELYX, INC. May 2, 2025 1 $1.61M 4 May 5, 2025 Director
ARDX ARDELYX, INC. Feb 24, 2025 1 $389K 4 Feb 26, 2025 Director
ARDX ARDELYX, INC. Jan 21, 2025 1 $993K 4 Jan 22, 2025 Director
ARDX ARDELYX, INC. Dec 26, 2024 2 $55K 4 Dec 27, 2024 Director
ARDX ARDELYX, INC. Dec 19, 2024 1 $997K 4 Dec 23, 2024 Director
ARDX ARDELYX, INC. Nov 13, 2024 1 $997K 4 Nov 14, 2024 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2024 1 $0 4 Jul 1, 2024 Director
ARDX ARDELYX, INC. Jun 14, 2024 2 $0 4 Jun 17, 2024 Director
NVAX NOVAVAX INC Jun 12, 2024 4 $248K 4 Jun 14, 2024 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 12, 2024 Director
MRSN Mersana Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
MRSN Mersana Therapeutics, Inc. Oct 2, 2023 1 $0 4 Oct 4, 2023 Director
MRSN Mersana Therapeutics, Inc. Jul 3, 2023 1 $0 4 Jul 6, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 3, 2023 1 $0 4 Jul 3, 2023 Director
ARDX ARDELYX, INC. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
NVAX NOVAVAX INC Jun 10, 2023 4 $0 4 Jun 13, 2023 Director
MRSN Mersana Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
MRSN Mersana Therapeutics, Inc. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
ARDX ARDELYX, INC. Nov 17, 2022 1 $1M 4 Nov 17, 2022 Director
EPZM Epizyme, Inc. Aug 12, 2022 3 $0 4 Aug 16, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2022 1 $0 4 Jul 1, 2022 Director
EPZM Epizyme, Inc. Jun 30, 2022 1 $23.7K 4 Jul 5, 2022 Director
NVAX NOVAVAX INC Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
ARDX ARDELYX, INC. Jun 15, 2022 2 $0 4 Jun 21, 2022 Director
NVAX NOVAVAX INC Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
MRSN Mersana Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ELVN IMARA Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
EPZM Epizyme, Inc. May 17, 2022 2 $0 4 May 19, 2022 Director
EPZM Epizyme, Inc. Mar 31, 2022 1 $23.8K 4 Apr 1, 2022 Director
ELVN IMARA Inc. Feb 18, 2022 3 $220K 4 Feb 23, 2022 Director
ELVN IMARA Inc. Feb 15, 2022 3 $54.7K 4 Feb 17, 2022 Director
ELVN IMARA Inc. Feb 10, 2022 3 $39.2K 4 Feb 14, 2022 Director
MRSN Mersana Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
EPZM Epizyme, Inc. Dec 31, 2021 1 $23.8K 4 Jan 4, 2022 Director
EPZM Epizyme, Inc. Sep 30, 2021 1 $23.8K 4 Oct 1, 2021 Director
NVAX NOVAVAX INC Sep 23, 2021 5 -$6.31M 4 Sep 24, 2021 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
EPZM Epizyme, Inc. Jun 30, 2021 1 $23.7K 4 Jul 1, 2021 Director
ELVN IMARA Inc. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
NVAX NOVAVAX INC Jun 17, 2021 2 $0 4 Jun 22, 2021 Director
ARDX ARDELYX, INC. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director
EPZM Epizyme, Inc. Jun 11, 2021 2 $0 4 Jun 15, 2021 Director